Document is current
Any future updates will be listed below
-
Authors
Tuomela, Karoliina https://orcid.org/0000-0003-1631-7435
Levings, Megan K. https://orcid.org/0000-0002-0305-5790
-
Funding
Funding for this research was provided by:
Juvenile Diabetes Research Foundation Canada (3-COE-2022-1103-M-B)
Canadian Institutes of Health Research (DT4-179512)
Canadian Institutes of Health Research (MFE-187807)
- License Information
-
More Information
Article History
Received: 3 September 2023
Accepted: 7 November 2023
First Online: 18 January 2024
Funding
: KT is supported by the J. Andrew McKee Fellowship in Type 1 Diabetes and CIHR Postdoctoral fellowship. MKL receives a salary award from the BC Children's Hospital Research Institute and is a Canada Research Chair in Engineered Immune Tolerance.
: MKL is an inventor on pending patents related to HLA-A2-specific CARs. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: KT researched and wrote the review and assembled figures/table. All authors were responsible for editing and critical review of content. All authors approved the version to be published.
Free to read: This content has been made available to all.
